Harvey N. Masonson
Keine laufenden Positionen mehr
Karriereverlauf von Harvey N. Masonson
Ehemalige bekannte Positionen von Harvey N. Masonson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 01.01.2018 | 01.01.2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
(OSI) Eyetech
 (OSI) Eyetech Medical SpecialtiesHealth Technology OSI Eyetech provides medical services. It is specializee in the development and commercialization of therapeutics to treat diseases of the eye. The company is headquartered in New York City, NY. | Corporate Officer/Principal | - | - |
| Sanofi-Synthelabo, Inc. | Chief Tech/Sci/R&D Officer | - | - |
| IVERIC BIO, INC. | Chief Tech/Sci/R&D Officer | - | - |
Ausbildung von Harvey N. Masonson
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology OSI Eyetech provides medical services. It is specializee in the development and commercialization of therapeutics to treat diseases of the eye. The company is headquartered in New York City, NY. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
| Sanofi-Synthelabo, Inc. | Health Technology |
- Börse
- Insiders
- Harvey N. Masonson
- Erfahrung
